Market Tracker

10/31 10:00pm ET

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

8.03
Data as of Oct 31
 -0.02 / -0.25%
Today’s Change
6.12
Today|||52-Week Range
11.47
+6.50%
Year-to-Date
No recent news for Supernus Pharmaceuticals Inc.

Today’s Trading

Previous close8.05
Today’s open8.24
Day’s range7.96 - 8.28
Volume208,555
Average volume (3 months)404,406
Market cap$344.7M
Dividend yield--
Data as of 3:59pm ET, 10/31/2014

Growth & Valuation

Earnings growth (last year)-6.62%
Earnings growth (this year)+100.45%
Earnings growth (next 5 years)--
Revenue growth (last year)+712.09%
P/E ratioNM
Price/Sales19.98
Price/Book9.59

Competitors

 Today’s
change
Today’s
% change
TKAITokai Pharmaceutical...-0.17-1.09%
ZIOPZIOPHARM Oncology In...+0.26+8.50%
VVUSVIVUS Inc+0.04+1.04%
XNCRXencor Inc+0.29+2.76%
Data as of 3:59pm ET, 10/31/2014

Financials

Next reporting dateNovember 5, 2014
EPS forecast (this quarter)$0.44
Annual revenue (last year)$12.0M
Annual profit (last year)-$92.3M
Net profit margin-767.73%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Director &
Secretary
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts